Biography
Donald Barone, DO
Instructor of Neurology
Education and Training
| Medical School: | Philadelphia College of Osteopathic Medicine, Philadelphia, PA |
| Internship: | University of Medicine and Dentistry of New Jersey, Stratford, NJ |
| Residency: | Neurology - University of Vermont College of Medicine, Colchester, VT |
| Fellowship: | Neuromuscular Disorders - Columbia Presbyterian Medical Center, New York, NY |
Board Certifications
- Neurology
About Me
Donald A. Barone, DO, MBA, received his BA in Biological Sciences from Rutgers College and his DO from Philadelphia College of Osteopathic Medicine. He served as a neurology resident at the University of Vermont College of Medicine, trained by Dr. Charles Poser and Dr. George Schumacher, two of the pioneers in Multiple Sclerosis research and clinical care. Following residency, he was awarded a Muscular Dystrophy Association (MDA)-funded fellowship in Neuromuscular Diseases under the tutelage of Dr. Lewis Rowland, Chair of Neurology at Columbia University College of Physicians and Surgeons, Columbia-Presbyterian Medical Center. Some of his early research involved microphysiological and electron microscopic study of the neuromuscular junction in the sternothyroid muscle from the animal model of Myasthenia Gravis.
Dr. Barone directed a grant-funded MDA clinic for over 30 years. His focus on Clinical Neuro-Immunology/Multiple Sclerosis evolved over the last 25 years, coinciding with the evolution of immunotherapies for Multiple Sclerosis and related disorders. He is a well-recognized expert in the clinical care and clinical research of Multiple Sclerosis and related-disorder patients. He has published and presented research findings at multiple domestic and international venues. He has been a medical educator his whole career, coming to Cooper from Rowan University SOM, where he was Professor and Chief, Division of Neurology. He earned his MBA in 2018 from Temple University Fox School of Business. He has cultivated an interest in health care business operational and financial models, especially as they evolve to accommodate the expected future changes in health care economic and re-imbursement models.